Healthcare Policy

Healthcare Policy

PPIs Could Be Bad News for Oral Cancer Therapies

A substantial proportion of patients with cancer use PPIs, and up to one-third of these patients are also using oral cancer treatments that could be adversely affected by concomitant PPI use.

Patient Support Improves Oral Antitumor Drug Safety

New oral antitumor drugs that have been approved since the early 2000s, like kinase inhibitors, have significantly improved outcomes for patients with many types of cancer.

Oncology Times - Latest Articles
CAR-T Cell Strategy to Target the Loss of Genes in Cancer

A team of researchers developed a new CAR-T cell approach to target a genetic change that commonly occurs in all types of cancer. This genetic alteration, termed LOH, occurs in cancer when...

Oncology Times - Latest Articles

Germline Genetic Testing for All Patients With Cancer?

Such testing can identify mutations that may warrant a change of treatment and allow trying a targeted therapy, and it can also guide screening for high-risk individuals and their family members.

Study Finds Need to Improve Knowledge About Palliative Care Among U.S. Adults

The use of palliative care in hospitals in the United States has steadily risen over the past decade, with almost universal access to services in large hospitals and academic medical centers.

The ASCO Post
Vaccine Shows Promise Against Multiple Tumor Types

Results from a Phase I clinical trial suggest that administration of a neoantigen vaccine developed using a computational platform cause no serious safety concerns while...

Oncology Times - Latest Articles
Oncology Hospital-at-Home Program Reduced Unplanned Health-Care Utilization and Costs

Mooney et al find that an oncology hospital-at-home program reduces unplanned health-care utilization and costs vs usual care among patients with cancer discharged from the hospital.

The ASCO Post
Study Finds Income Eligibility Limits for Medicaid May Be Associated With Worse Long-Term Survival Among Newly Diagnosed Patients With Cancer

A study investigating the association between state Medicaid income eligibility limits and long-term survival among newly diagnosed patients with cancer has found that patients living in states wit

The ASCO Post
Surveillance Protocol and Early Cancer Detection in Patients With Constitutional Mismatch Repair Deficiency Syndrome

Use of an IRRDC surveillance protocol is associated with improved OS among patients with CMMRD, a cancer predisposition syndrome associated with inheritance of biallelic pathogenic variants in mism

The ASCO Post
Possible Obesity Effect Detected in Cancer Death Rates

The obesity epidemic in the United States may be slowing improvements in cancer mortality, according to a new analysis of over 50 million cancer and heart disease deaths.

Effect of Oral Chemotherapy Management Program on Capecitabine Toxicity

This study finds that implementation of an oral CT management program is associated with reduced rates of any-grade and severe capecitabine toxicity, less frequent toxicity-related...

The ASCO Post
Vitamins to Prevent Cancer and CVD: No, Says USPSTF

For most vitamin and mineral supplements, there is not enough evidence to recommend for or against taking them to prevent cancer and CVD, according to new draft recommendations from the US Preventi

Safety and Immunogenicity of One versus Two Doses of the COVID-19 Vaccine BNT162b2 for Patients With Cancer

This study examines the safety and immunogenicity of the BNT162b2 vaccine in patients with cancer.

The Lancet Oncology
Effect of Antihypertensive Medications on Risk of Cancer

Emma Copland and colleagues find “no consistent evidence” of an association between antihypertensive treatment and risk for cancer. 

The ASCO Post
Advancing Cancer Care in the Black Community

African Americans face a higher burden from cancer compared to other racial/ethnic groups in the U.S., and an even greater obstacle to cancer prevention, detection, treatment, and survival.

Oncology Times - Latest Articles
Rankings of Most Common Cancers to Shift Over Next 20 Years

The next 20 years will see a big shift in cancer type rankings, researchers predict.

Study Evaluates Method to Reduce Medication Errors and Side Effects of Newer Oral Anticancer Drugs

Dürr et al found that an intensified clinical pharmacologic/pharmaceutical care initiative reduced medication errors and severe side effects among patients receiving newer oral anticancer drugs.

The ASCO Post
Cancer Screening Stopped by Pandemic: Repercussions to Come?

Last year, cancer screening programs around the world ground to a halt as SARS-CoV-2 infection rates surged globally. The effect of this slowdown is now becoming clear.

NCCN Issues Guidance on COVID-19 Vaccination for Patients With Cancer

Oncology groups including ASCO, ASH, and the American Society for Radiation Oncology have all recommended patients with cancer get vaccinated. Now the NCCN has published a similar guidance.

Oncology Times - Latest Articles
Medicaid Expansion Is Associated With Earlier Diagnosis of Gastric Cancer, Improved Survival

Medicaid expansion caused a decrease in uninsured patients and led to an earlier diagnosis of gastric cancer with an associated increase in 1-year survival.

The ASCO Post
Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain

This study examines the predictors for and frequency of the presence of nonmedical opioid use behavior in patients with cancer.

JAMA Oncology
Community Oncologists Balk at Home Chemo's Financial Effects

Until now, the two choices have been hospital outpatient departments or physician-owned oncology practices; if a patient's home becomes a third alternative, a new entity — home-infusion pharmacies

Don't Delay: Patients With Cancer Need Both Doses of COVID Vax

Delaying the second dose can leave most patients with cancer wholly or partially unprotected. 

US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer

In this cross-sectional analysis of CSC guidelines, 55% deprioritized some patients with cancer, and 26% categorically excluded some patients with cancer during...

JAMA Oncology
mRNA Vaccine for Cancer Immunotherapy

This review provides a detailed overview of the recent progress and existing challenges of mRNA cancer vaccines and future considerations of applying mRNA vaccine for cancer immunotherapies.

Molecular Cancer
Evaluating Mental Health–Related Symptoms Among Cancer Survivors During the COVID-19 Pandemic

This study's aim is to evaluate mental health symptoms and identify associated determinants among cancer survivors during the COVID-19 pandemic in the United States.

JCO Oncology Practice
Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With Cancer

This study examines the clinical characteristics, experiences, and outcomes of transgender patients with cancer.

JAMA Oncology
COVID-19-Positive Cancer Patients Undergoing Active Anticancer Treatment

This study aims to describe the clinical characteristics and outcomes of patients diagnosed with COVID-19 whilst on anticancer treatment in a developing country.

New Study Confirms Pandemic's Harmful Effects on Cancer Care

A new study shows that the COVID-19 pandemic has resulted in major declines in cancer screening, diagnosis, and treatment of American seniors and Medicare beneficiaries in 2020.

Oncology Times - Latest Articles
EMA Panel Endorses Approval of Five New Cancer Drugs

The drug review panel for the European Medicines Agency has endorsed the approval of several cancer therapies.

Primary care healthcare policy implementation in the Eastern Mediterranean region

This paper describes and analyses the health systems of Algeria, Kuwait, Morocco, Saudi Arabia, Jordan and Iraq to PHC.

European Journal of General Practice
Policy statement from the Society for Healthcare Epidemiology of America (SHEA): Only medical contraindications should be accepted as a reason for not receiving all routine immunizations as recommended by the Centers for Disease Control and Prevention.

SHEA endorses adhering to the recommendations by CDC and ACIP for immunizations of all children adults.

Infection Control and Hospital Epidemiology

source list reference